Literature DB >> 14751833

Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain.

Victor E Marquez1, Ramon Eritja, James A Kelley, Dana Vanbemmel, Judith K Christman.   

Abstract

A short oligodeoxynucleotide (ODN) with 2-(1H)-pyrimidinone at the HhaI DNA methyltransferase target site (GCGC) is shown to induce a level of inhibition of methyl transfer and thermal stability of the complex with the enzyme identical to that achieved with a similar ODN substituted with 5-azacytosine. The drugs responsible for these effects-zebularine and 5-azacytidine/2'-deoxy-5-azacytidine-are contrasted in terms of chemical stability and possible metabolic activation by a brief structure-activity analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14751833     DOI: 10.1196/annals.1281.014

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.

Authors:  Jesper B Andersen; Valentina M Factor; Jens U Marquardt; Chiara Raggi; Yun-Han Lee; Daekwan Seo; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Sci Transl Med       Date:  2010-10-20       Impact factor: 17.956

2.  Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli.

Authors:  Brittany Betham; Sophia Shalhout; Victor E Marquez; Ashok S Bhagwat
Journal:  DNA Repair (Amst)       Date:  2009-12-11

3.  DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.

Authors:  Dana M van Bemmel; Adam S Brank; Ramon Eritja; Victor E Marquez; Judith K Christman
Journal:  Biochem Pharmacol       Date:  2009-05-23       Impact factor: 5.858

4.  Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.

Authors:  Christine Champion; Dominique Guianvarc'h; Catherine Sénamaud-Beaufort; Renata Z Jurkowska; Albert Jeltsch; Loïc Ponger; Paola B Arimondo; Anne-Laure Guieysse-Peugeot
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.